Investor Webinar
Released
Latest announcements
Announcement summary
Investor Webinar
Cynata's CEO and MD, Dr Kilian Kelly and CBO Dr Mathias Kroll, provided an update to investors, following the release of the ASX Quarterly Activity Report for the December 2024 quarter.
We invite all to use the Q&A function for any questions you have for management.
Ask a question
Your question will be sent privately to Cynata Therapeutics. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Cynata Therapeutics a question about this announcement.